Skip to main content
Livermore
Livermore
ZHEN

Immunic, Inc.

IMUX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001280776

No open-market purchases or sales by Immunic, Inc. insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q2 2026, worth $130.6M in total; no superinvestor holds it.

Holders of 5% or more of IMUX

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Immunic, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of IMUX
HolderLatest formStakeChangeFirst filedLatest filingFiling
Vivo Opportunity Fund Holdings, L.P.13G9.99%29.1M sharesNewFeb 20, 20261 filingFeb 20, 2026SEC
Biotechnology Value Fund L P13D9.99%13.6M shares0.00 ppfrom 9.99%Aug 14, 20252 filingsFeb 20, 2026SEC
Janus Henderson Group PLC13G9.99%12.0M shares+6.99 ppfrom 3.00%Feb 14, 20252 filingsDec 8, 2025SEC
Adage Capital Management, L.P.13G/A9.99%10.5M shares+8.44 ppfrom 1.55%Feb 12, 20252 filingsAug 12, 2025SEC
Commodore Capital LP13G9.90%13.4M sharesNewFeb 24, 20261 filingFeb 24, 2026SEC
Trails Edge Capital Partners, LP13G8.70%11.5M sharesNewFeb 24, 20261 filingFeb 24, 2026SEC
Deep Track Capital, LP13G8.69%11.5M sharesNewMar 4, 20261 filingMar 4, 2026SEC
Nantahala Capital Management, LLC13G/A8.22%10.4M shares−1.77 ppfrom 9.99%Aug 14, 20252 filingsFeb 13, 2026SEC
Standard Life Aberdeen plc13G/A6.85%8.24M shares−1.75 ppfrom 8.60%Jul 31, 20252 filingsFeb 2, 2026SEC
Alyeska Investment Group, L.P.13G/A6.24%7.50M shares−3.11 ppfrom 9.35%Aug 14, 20253 filingsFeb 17, 2026SEC
683 Capital Management, LLC13G/A5.90%7.50M shares−4.00 ppfrom 9.90%Aug 8, 20252 filingsFeb 17, 2026SEC
Soleus Capital Master Fund, L.P.13G5.50%6.79M sharesNewFeb 19, 20261 filingFeb 19, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

27 Schedule 13D and 13G filings on Immunic, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on IMUX
Filed (ET)FilerFormStakeChangeEvent dateFiling
Mar 4, 20264:15 PM ETDeep Track Capital, LPand 3 others13G8.69%11.5M sharesNewFeb 17, 2026SEC
Feb 24, 20264:38 PM ETCommodore Capital LPand 3 others13G9.90%13.4M sharesNewFeb 17, 2026SEC
Feb 24, 20264:15 PM ETTrails Edge Capital Partners, LPand 2 others13G8.70%11.5M sharesNewFeb 17, 2026SEC
Feb 20, 20266:59 PM ETBiotechnology Value Fund L Pand 10 others13D9.99%13.6M shares0.00 ppfrom 9.99%Feb 12, 2026SEC
Feb 20, 20264:43 PM ETVivo Opportunity Fund Holdings, L.P.and 3 others13G9.99%29.1M sharesNewFeb 17, 2026SEC
Feb 19, 20264:30 PM ETSoleus Capital Master Fund, L.P.and 5 others13G5.50%6.79M sharesNewFeb 17, 2026SEC
Feb 17, 20264:41 PM ETAlyeska Investment Group, L.P.and 2 others13G/A6.24%7.50M shares−3.11 ppfrom 9.35%Dec 31, 2025SEC
Feb 17, 20264:18 PM ET683 Capital Management, LLCand 2 others13G/A5.90%7.50M shares−4.00 ppfrom 9.90%Dec 31, 2025SEC
Feb 13, 20265:05 PM ETNantahala Capital Management, LLCand 2 others13G/A8.22%10.4M shares−1.77 ppfrom 9.99%Dec 31, 2025SEC
Feb 2, 202610:31 AM ETStandard Life Aberdeen plcand 1 other13G/A6.85%8.24M shares−1.75 ppfrom 8.60%Dec 31, 2025SEC
Dec 8, 202511:45 AM ETJanus Henderson Group PLC13G9.99%12.0M shares+6.99 ppfrom 3.00%Nov 28, 2025SEC
Nov 14, 20258:04 PM ETAlyeska Investment Group, L.P.and 2 others13G/A9.35%11.3M shares−0.55 ppfrom 9.90%Sep 30, 2025SEC
Nov 14, 20251:39 PM ETAvidity Partners Management LPand 4 others13G/A4.80%4.70M shares−1.10 ppfrom 5.90%Below 5%Sep 30, 2025SEC
Nov 7, 20254:00 PM ETSoleus Private Equity Fund III, L.P.and 8 others13G/A1.60%1.58M shares–Below 5%Sep 30, 2025SEC
Aug 14, 20255:38 PM ETAlyeska Investment Group, L.P.and 2 others13G9.90%9.49M sharesNewJun 30, 2025SEC
Aug 14, 20254:44 PM ETNantahala Capital Management, LLCand 2 others13G9.99%10.6M sharesNewJun 30, 2025SEC
Aug 14, 20254:02 PM ETBiotechnology Value Fund L Pand 9 others13G/A9.99%9.79M shares–Jun 30, 2025SEC
Aug 14, 20252:37 PM ETAvidity Partners Management LPand 5 others13G/A5.90%5.62M shares−0.70 ppfrom 6.60%Jun 30, 2025SEC
Aug 12, 20259:05 AM ETAdage Capital Management, L.P.and 2 others13G/A9.99%10.5M shares+8.44 ppfrom 1.55%Jun 30, 2025SEC
Aug 8, 20254:05 PM ET683 Capital Management, LLCand 2 others13G9.90%10.6M sharesNewAug 2, 2025SEC
Jul 31, 20253:46 PM ETStandard Life Aberdeen plcand 1 other13G8.60%8.24M sharesNewJun 30, 2025SEC
May 15, 20252:07 PM ETAvidity Partners Management LPand 5 others13G/A6.60%6.04M shares−3.30 ppfrom 9.90%Mar 31, 2025SEC
May 15, 20258:00 AM ETRTW Investments, LPand 1 other13G/A1.10%1.03M shares–Below 5%Mar 31, 2025SEC
Feb 14, 202511:36 AM ETJanus Henderson Group PLC13G/A3.00%2.69M shares–Below 5%Dec 31, 2024SEC
Feb 14, 202510:16 AM ETAvidity Partners Management LPand 6 others13G/A9.90%9.02M shares–Dec 31, 2024SEC
Feb 12, 20259:44 AM ETAdage Capital Management, L.P.and 2 others13G/A1.55%1.40M shares–Below 5%Dec 31, 2024SEC
Jan 30, 20259:57 PM ETVanguard Group Inc13G/A4.35%3.92M shares–Below 5%Dec 31, 2024SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Immunic, Inc. shares.

No Form 144 notices for Immunic, Inc. are on file.